First Time Loading...

Philogen SpA
MIL:PHIL

Watchlist Manager
Philogen SpA Logo
Philogen SpA
MIL:PHIL
Watchlist
Price: 17.9 EUR -1.1% Market Closed
Updated: May 22, 2024

Intrinsic Value

PHIL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Philogen SpA engages engineering and clinical development of lead products capable of targeting angiogenesis. [ Read More ]

The intrinsic value of one PHIL stock under the Base Case scenario is 24.1 EUR. Compared to the current market price of 17.9 EUR, Philogen SpA is Undervalued by 26%.

Key Points:
PHIL Intrinsic Value
Base Case
24.1 EUR
Undervaluation 26%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Philogen SpA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PHIL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Philogen SpA

Provide an overview of the primary business activities
of Philogen SpA.

What unique competitive advantages
does Philogen SpA hold over its rivals?

What risks and challenges
does Philogen SpA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Philogen SpA.

Provide P/S
for Philogen SpA.

Provide P/E
for Philogen SpA.

Provide P/OCF
for Philogen SpA.

Provide P/FCFE
for Philogen SpA.

Provide P/B
for Philogen SpA.

Provide EV/S
for Philogen SpA.

Provide EV/GP
for Philogen SpA.

Provide EV/EBITDA
for Philogen SpA.

Provide EV/EBIT
for Philogen SpA.

Provide EV/OCF
for Philogen SpA.

Provide EV/FCFF
for Philogen SpA.

Provide EV/IC
for Philogen SpA.

Show me price targets
for Philogen SpA made by professional analysts.

What are the Revenue projections
for Philogen SpA?

How accurate were the past Revenue estimates
for Philogen SpA?

What are the Net Income projections
for Philogen SpA?

How accurate were the past Net Income estimates
for Philogen SpA?

What are the EPS projections
for Philogen SpA?

How accurate were the past EPS estimates
for Philogen SpA?

What are the EBIT projections
for Philogen SpA?

How accurate were the past EBIT estimates
for Philogen SpA?

Compare the revenue forecasts
for Philogen SpA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Philogen SpA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Philogen SpA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Philogen SpA compared to its peers.

Compare the P/E ratios
of Philogen SpA against its peers.

Discuss the investment returns and shareholder value creation
comparing Philogen SpA with its peers.

Analyze the financial leverage
of Philogen SpA compared to its main competitors.

Show all profitability ratios
for Philogen SpA.

Provide ROE
for Philogen SpA.

Provide ROA
for Philogen SpA.

Provide ROIC
for Philogen SpA.

Provide ROCE
for Philogen SpA.

Provide Gross Margin
for Philogen SpA.

Provide Operating Margin
for Philogen SpA.

Provide Net Margin
for Philogen SpA.

Provide FCF Margin
for Philogen SpA.

Show all solvency ratios
for Philogen SpA.

Provide D/E Ratio
for Philogen SpA.

Provide D/A Ratio
for Philogen SpA.

Provide Interest Coverage Ratio
for Philogen SpA.

Provide Altman Z-Score Ratio
for Philogen SpA.

Provide Quick Ratio
for Philogen SpA.

Provide Current Ratio
for Philogen SpA.

Provide Cash Ratio
for Philogen SpA.

What is the historical Revenue growth
over the last 5 years for Philogen SpA?

What is the historical Net Income growth
over the last 5 years for Philogen SpA?

What is the current Free Cash Flow
of Philogen SpA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Philogen SpA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Philogen SpA

Current Assets 89.2m
Cash & Short-Term Investments 75.3m
Receivables 11.4m
Other Current Assets 2.5m
Non-Current Assets 30m
PP&E 25.9m
Intangibles 1.2m
Other Non-Current Assets 2.9m
Current Liabilities 12.7m
Accounts Payable 7.8m
Accrued Liabilities 1.2m
Other Current Liabilities 3.7m
Non-Current Liabilities 16m
Long-Term Debt 13m
Other Non-Current Liabilities 2.9m
Efficiency

Earnings Waterfall
Philogen SpA

Revenue
23.1m EUR
Cost of Revenue
-13.9m EUR
Gross Profit
9.3m EUR
Operating Expenses
-18.1m EUR
Operating Income
-8.8m EUR
Other Expenses
2.7m EUR
Net Income
-6.2m EUR

Free Cash Flow Analysis
Philogen SpA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PHIL Profitability Score
Profitability Due Diligence

Philogen SpA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
ROE is Increasing
31/100
Profitability
Score

Philogen SpA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

PHIL Solvency Score
Solvency Due Diligence

Philogen SpA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
74/100
Solvency
Score

Philogen SpA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHIL Price Targets Summary
Philogen SpA

Wall Street analysts forecast PHIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHIL is 23.97 EUR with a low forecast of 22.22 EUR and a high forecast of 26.25 EUR.

Lowest
Price Target
22.22 EUR
24% Upside
Average
Price Target
23.97 EUR
34% Upside
Highest
Price Target
26.25 EUR
47% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Philogen SpA

Shareholder Return

PHIL Price
Philogen SpA

1M 1M
-1%
6M 6M
+1%
1Y 1Y
+20%
3Y 3Y
+22%
5Y 5Y
+7%
10Y 10Y
+7%
Annual Price Range
17.9
52w Low
14.9
52w High
18.95
Price Metrics
Average Annual Return -8.29%
Standard Deviation of Annual Returns 6.84%
Max Drawdown -25%
Shares Statistics
Market Capitalization 519m EUR
Shares Outstanding 28 992 031
Percentage of Shares Shorted
N/A

PHIL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Philogen SpA Logo
Philogen SpA

Country

Italy

Industry

Biotechnology

Market Cap

519m EUR

Dividend Yield

0%

Description

Philogen SpA engages engineering and clinical development of lead products capable of targeting angiogenesis. The company is headquartered in Sovicille, Siena and currently employs 135 full-time employees. The company went IPO on 2021-03-03. The firm develops products and technologies for the diagnosis and therapy of serious human diseases. The company has three anti-cancer antibody derivatives, produced with an in-house industrial process, into Phase I/II clinical studies. The majority of its technologies and products are based on high-affinity human monoclonal antibody fragments. Philogen SpA developed a patented technology, Iterative Colony Filter Screening, for the isolation of monoclonal antibodies, which requires neither immunization nor phage display. The firm's subsidiaries are Philotec, Philomed and Philochem. Philogen SpA is headquartered in Siena, Italy.

Contact

SIENA
Sovicille
Via Bellaria, 35
+39057717816
https://www.philogen.com/

IPO

2021-03-03

Employees

135

Officers

Co-Founder & Executive Chairman
Dr. Duccio Neri
Co-Founder, CEO , MD, CSO, President of the Scientific Advisory Board & Director
Prof. Dario Neri Ph.D.
Co-Founder, Head of IP & Licensing and Executive Director
Dr. Giovanni Neri
Chief Financial Officer
Ms. Laura Baldi
Chief Medical Officer
Dr. Alfredo Covelli M.D.
Deputy CMO & Head of Clinical Operations
Dr. Katia Lorizzo

See Also

Discover More
What is the Intrinsic Value of one PHIL stock?

The intrinsic value of one PHIL stock under the Base Case scenario is 24.1 EUR.

Is PHIL stock undervalued or overvalued?

Compared to the current market price of 17.9 EUR, Philogen SpA is Undervalued by 26%.